Emerging Threats — Gene Doping and Myostatin Inhibition
The greatest challenge for sports integrity in 2026 is Gene Doping. This involves using viral vectors to deliver DNA that tells the body to produce more natural enhancers, such as IGF-1 or Myostatin inhibitors.
Because the resulting hormones are "natural" to the patient's own body, they are nearly impossible to distinguish from genetic outliers. In 2026, WADA-accredited labs have begun implementing "Transgene Detection" tests, which look for the specific genetic sequences used in the viral vectors rather than the hormone itself. This technology is currently being deployed at major 2026 international competitions to deter "permanent" genetic modification.
2 Views
